[How I manage respiratory syncytial virus, human herpesvirus 6 and adenovirus reactivation or infection after allogeneic stem cell transplantation: a report of the SFGM-TC]

Pathol Biol (Paris). 2013 Aug;61(4):149-51. doi: 10.1016/j.patbio.2013.07.012. Epub 2013 Sep 4.
[Article in French]

Abstract

In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of virus respiratory syncytial virus (RSV), human herpes virus 6 (HHV6) or adenovirus allogeneic Stem Cell Transplantation.

Keywords: Adenovirus; Adénovirus; Allogeneic SCT; Allogreffe de CSH; Antiviral therapy; HHV6; Infections virales; RSV; Traitement antiviral; VRS; Viral infections.

Publication types

  • Practice Guideline

MeSH terms

  • Adenoviridae / physiology
  • Adenoviridae Infections / epidemiology
  • Adenoviridae Infections / etiology
  • Adenoviridae Infections / therapy*
  • Consensus
  • Donor Selection / standards
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / standards
  • Hematopoietic Stem Cell Transplantation / statistics & numerical data
  • Herpesvirus 6, Human / physiology
  • Humans
  • Immunosuppression Therapy / standards
  • Immunosuppression Therapy / statistics & numerical data
  • Respiratory Syncytial Virus Infections / epidemiology
  • Respiratory Syncytial Virus Infections / etiology
  • Respiratory Syncytial Virus Infections / therapy*
  • Respiratory Syncytial Viruses / physiology
  • Roseolovirus Infections / epidemiology
  • Roseolovirus Infections / etiology
  • Roseolovirus Infections / therapy*
  • Transplantation, Homologous
  • Virus Activation / physiology*